Terms: = Germ cell tumor AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
111 results:
1. Insulin-like growth factor 2 mRNA-binding protein 3 enhanced melanoma migration through regulation of AKT1 and RELA expression.
Sheen YS; Syu YJ; Chang YC; Hsieh PH; Liao YH; Lin MH; Chen CY; Chu CY; Chu CY
Exp Dermatol; 2024 Jan; 33(1):e15015. PubMed ID: 38284203
[TBL] [Abstract] [Full Text] [Related]
2. Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cells.
Graf SD; Keber CU; Hattesohl A; Teply-Szymanski J; Hattesohl S; Guder M; Gercke N; Di Fazio P; Slater EP; Jesinghaus M; Denkert C; Bartsch DK; Lehman B
J Neuroendocrinol; 2024 Feb; 36(2):e13364. PubMed ID: 38246597
[TBL] [Abstract] [Full Text] [Related]
3. CircDLGAP4 overexpression ameliorates neuronal injury in Parkinson's disease by binding to EIF4A3 and increasing hmga2 expression.
Bao H; Zhang Q; Li Y; Nie C
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23530. PubMed ID: 37822284
[TBL] [Abstract] [Full Text] [Related]
4. Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age.
Shields CL; Samuelson AG; Oh GJ; DeSimone JD; Sajjadi ZL; Bas Z; Kalafatis NE; Lally SE; Shields JA; Dockery PW
Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):7. PubMed ID: 37418273
[TBL] [Abstract] [Full Text] [Related]
5. Investigation of radiomics and deep convolutional neural networks approaches for glioma grading.
Aouadi S; Torfeh T; Arunachalam Y; Paloor S; Riyas M; Hammoud R; Al-Hammadi N
Biomed Phys Eng Express; 2023 Mar; 9(3):. PubMed ID: 36898146
[No Abstract] [Full Text] [Related]
6. Transdermal nanolipoplex simultaneously inhibits subcutaneous melanoma growth and suppresses systemically metastatic melanoma by activating host immunity.
Chen CH; Weng TH; Chuang CH; Huang KY; Huang SC; Chen PR; Huang HH; Huang LY; Shen PC; Chuang PY; Huang HY; Wu YS; Chang HC; Weng SL; Liao KW
Nanomedicine; 2023 Jan; 47():102628. PubMed ID: 36400317
[TBL] [Abstract] [Full Text] [Related]
7. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
8. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
[TBL] [Abstract] [Full Text] [Related]
9. CircABCC1 promotes the development of glioma by sponging miR-591 and modulating high-mobility group A2.
Wang L; Tan Y; Chen J; Zhu Z; Zhu Y; Sun Q; Dong H; Ai C; He G; Liu Y
Ann N Y Acad Sci; 2022 May; 1511(1):107-118. PubMed ID: 35000195
[TBL] [Abstract] [Full Text] [Related]
10. Targeting immunoliposomes to EGFR-positive glioblastoma.
Kasenda B; König D; Manni M; Ritschard R; Duthaler U; Bartoszek E; Bärenwaldt A; Deuster S; Hutter G; Cordier D; Mariani L; Hench J; Frank S; Krähenbühl S; Zippelius A; Rochlitz C; Mamot C; Wicki A; Läubli H
ESMO Open; 2022 Feb; 7(1):100365. PubMed ID: 34998092
[TBL] [Abstract] [Full Text] [Related]
11. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy.
Mao Y; Sun Y; Wu Z; Zheng J; Zhang J; Zeng J; Lee C; Kim JK
Cell Death Dis; 2021 Dec; 12(12):1141. PubMed ID: 34887387
[TBL] [Abstract] [Full Text] [Related]
12. Neuroblastoma GD2 Expression and Computational Analysis of Aptamer-Based Bioaffinity Targeting.
Sabbih GO; Danquah MK
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445807
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic malignant melanoma mimicking a salivary gland basaloid neoplasm after treatment with nivolumab.
Lajara S; Landau M
Diagn Cytopathol; 2021 Sep; 49(9):E370-E373. PubMed ID: 34174024
[TBL] [Abstract] [Full Text] [Related]
14. Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice.
Ouyang J; Jiang Y; Deng C; Zhong Z; Lan Q
Int J Nanomedicine; 2021; 16():4105-4115. PubMed ID: 34163162
[TBL] [Abstract] [Full Text] [Related]
15. Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy.
Fei W; Zhao Y; Wu X; Sun D; Yao Y; Wang F; Zhang M; Li C; Qin J; Zheng C
J Nanobiotechnology; 2021 Jun; 19(1):184. PubMed ID: 34130695
[TBL] [Abstract] [Full Text] [Related]
16. Sphingosine 1-Phosphate liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against Brain Glioma tumors.
Liu Y; Wang X; Li J; Tang J; Li B; Zhang Y; Gu N; Yang F
Adv Mater; 2021 Jul; 33(30):e2101701. PubMed ID: 34106489
[TBL] [Abstract] [Full Text] [Related]
17. Peptide Gene Delivery Vectors for Specific Transfection of Glioma cells.
Wang T; Meng Z; Kang Z; Ding G; Zhao B; Han Z; Zheng Z; Wang C; Meng Q
ACS Biomater Sci Eng; 2020 Dec; 6(12):6778-6789. PubMed ID: 33320593
[TBL] [Abstract] [Full Text] [Related]
18. Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis.
Mahtab A; Rabbani SA; Neupane YR; Pandey S; Ahmad A; Khan MA; Gupta N; Madaan A; Jaggi M; Sandal N; Rawat H; Aqil M; Talegaonkar S
Carbohydr Polym; 2020 Dec; 250():116926. PubMed ID: 33049840
[TBL] [Abstract] [Full Text] [Related]
19. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery.
Zheng Z; Zhang J; Jiang J; He Y; Zhang W; Mo X; Kang X; Xu Q; Wang B; Huang Y
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817393
[TBL] [Abstract] [Full Text] [Related]
20. Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Yaman Ü; Aslan M; Ozturk S; Ulubayram K; Eroğlu İ
Pharm Dev Technol; 2020 Dec; 25(10):1192-1203. PubMed ID: 32729757
[TBL] [Abstract] [Full Text] [Related]
[Next]
